See Figure 3. Algorithm for the management of type 2 diabetes from AFP (http://www.aafp.org/afp/20040801/489.html).
For patients who have been inadequately controlled on oral hypoglycemics, the initial dose is typically 10 units/day or 0.1 to 0.2 units/kg/day. Initially, basal therapies are usually administered as a single dose in the evening. Where necessary, NPH insulin also may be given in 2 doses: 1 dose in the morning and 1 dose in the evening. The dose can be titrated in 1-, 2-, or 3-unit increments until target FPG levels are achieved. When initiating insulin, it is best to start low and increase the dose gradually until the target is reached (http://www.ispub.com).
If intermediate insulin is chosen, the amount can be calculated by dividing a patient’s body weight in kilograms by four and using that number to determine the starting dose (resulting in one fourth of the regular dose) or
In subjects with type 2 diabetes who are poorly controlled on oral hypoglycemics, initiating insulin therapy with twice-daily BIAsp 70/30 was more effective in achieving HbA1c targets than once-daily glargine (Lantus), especially in subjects with HbA1c >8.5% (http://care.diabetesjournals.org/cgi/content/abstract/28/2/260).
The INITIATE (INITiation of Insulin to reach A1c TargEt) study provides guidelines for twice-daily initiation of insulin (aspart premix 70/30). Begin with 6 units twice a day if the FPG is 180 mg/dL or greater, and 5 units twice a day if the FPG is less than 180 mg/dL (http://www.medscape.com/viewarticle/567952).
References listed in the text above. Original post by Clinical Cases
Image source: Wikipedia, public domain.
